CAG
KYTH

Crestwood Advisors Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Crestwood Advisors Group’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,105
Closed -$308K – 162
2015
Q3 		$308K Sell
4,105
-1,900
-32% -$142K 0.04% 111
2015
Q2 		$452K Buy
+6,005
New +$322K 0.06% 91

Crestwood Advisors Group's KYTH Position: Q4 2015 in Review

Crestwood Advisors Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 4,105 shares — an estimated $308K sold.

Crestwood Advisors Group first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $452K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Crestwood Advisors Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Crestwood Advisors Group sold 4,105 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $308K.
  • Crestwood Advisors Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Crestwood Advisors Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $452K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Crestwood Advisors Group's 13F filing for Q4 2015, filed 12 Feb 2016.